Key statistics
On Thursday, Context Therapeutics Inc (CNTX:NAQ) closed at 2.43, -14.74% below its 52-week high of 2.85, set on Jan 30, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.44 |
|---|---|
| High | 2.58 |
| Low | 2.40 |
| Bid | 2.37 |
| Offer | 2.41 |
| Previous close | 2.44 |
| Average volume | 2.10m |
|---|---|
| Shares outstanding | 91.88m |
| Free float | 90.79m |
| P/E (TTM) | -- |
| Market cap | 224.19m USD |
| EPS (TTM) | -0.2835 USD |
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
- Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
- Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
- Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
More ▼
